Jan Pinkas

Company: Pyxis Oncology

Job title: Chief Scientific Officer

Seminars:

C-Suite Fireside Chat – Strategizing the Search for the Next ADC Target to Dominate the Limelight – Where is the Next Best Target? 9:00 am

Scoping the current state of the ADC landscape to understand the white space in target selection and the gaps to exploit Collaborating to outline the lessons learned from traditional ADC targets, including HER2, to hypothesize the qualities of a successful target Proposing the realistic expectations for ADC target selection in 2025 and earmarking the predicted…Read more

day: Conference Day One

Breaking Down the Complex Mechanisms of Action of the ADC Target With an Appreciation of Changes Over Time With Disease Progression 2:30 pm

Conveying an ADC target selection strategy capable of visualizing target expression over time, across varying disease outcomes Focusing on properties of targets which lend themselves to full regeneration post ADC internalization, as well as those which fail to regenerate Measuring the levels of target expression over time in both healthy and tumorigenic cells to inform…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.